|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6100 CAD | -8.96% |
|
-4.69% | -12.86% |
| 05-13 | Grown Rogue International Inc., Q1 2026 Earnings Call, May 12, 2026 | |
| 05-13 | Grown Rogue International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | |||||||||
New Jersey | - | - | - | - | 11.34M | ||||
Interest Expense | - | - | - | - | -130K | ||||
Income Tax Expense | - | - | - | - | 119K | ||||
EBT | - | - | - | - | 4.63M | ||||
Gross Profit | - | - | - | - | 6.06M | ||||
EBITDA | - | - | - | - | 6.02M | ||||
D&A | - | - | - | - | 244K | ||||
Net Income | - | - | - | - | 4.51M | ||||
Oregon | - | - | 11M | 12.09M | 11.06M | ||||
Total Assets | - | - | 6.64M | - | - | ||||
Interest Expense | - | - | - | - | -10K | ||||
EBT | - | - | - | - | 481K | ||||
Gross Profit | - | - | 4.62M | 5.18M | 3.16M | ||||
EBITDA | - | - | - | - | 1.16M | ||||
D&A | - | - | - | - | 213K | ||||
Net Income | - | - | - | - | 481K | ||||
Michigan | - | - | 11.42M | 12.94M | 10.03M | ||||
Total Assets | - | - | 4.02M | - | - | ||||
Interest Expense | - | - | - | - | -14.13K | ||||
Income Tax Expense | - | - | - | - | -104K | ||||
EBT | - | - | - | - | 2.31M | ||||
Gross Profit | - | - | 6.65M | 6.48M | 4.93M | ||||
EBITDA | - | - | - | - | 3.38M | ||||
D&A | - | - | - | - | 185K | ||||
Net Income | - | - | - | - | 2.42M | ||||
Consulting Services | |||||||||
Corporate | - | - | 929K | 1.99M | - | ||||
Interest Expense | - | - | - | - | -1.23M | ||||
Income Tax Expense | - | - | - | - | 1.59M | ||||
EBT | - | - | - | - | -2.59M | ||||
Gross Profit | - | - | 620K | 1.78M | - | ||||
EBITDA | - | - | - | - | -5.17M | ||||
D&A | - | - | - | - | 60.07K | ||||
Net Income | - | - | - | - | -4.18M | ||||
Total Assets | - | - | 1.36M | - | - | ||||
Medicinal Chemicals and Botanical Products | |||||||||
Pharmaceuticals | 9.38M | 17.76M | - | - | - | ||||
Total Assets | 14.21M | 16.37M | - | - | - | ||||
Interest Expense | -1.15M | -894K | - | - | - | ||||
Income Tax Expense | 151K | 245K | - | - | - | ||||
CAPEX | -2.05M | -1.11M | - | - | - | ||||
EBT | -864K | 665K | - | - | - | ||||
Gross Profit | 6.1M | 8.12M | - | - | - | ||||
D&A | 185K | 751K | - | - | - | ||||
Operating Income | 702K | 957K | - | - | - | ||||
Net Income | -2.41M | 447K | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
United States | 9.38M | 17.76M | 23.35M | 27.02M | 32.43M | ||||
Total Assets | 14.21M | 16.37M | 30.16M | 43.32M | 62.74M | ||||
Interest Expense | -1.15M | -894K | -1.4M | -2.42M | -1.38M | ||||
Income Tax Expense | 151K | 245K | 371K | 1.7M | 1.6M | ||||
D&A | 185K | 751K | 579K | 940K | 702K | ||||
CAPEX | -2.05M | -1.11M | -1.46M | -1.74M | -4.66M | ||||
Gross Profit | 6.1M | 8.12M | 12.67M | 13.44M | 14.15M | ||||
Net Income | -2.41M | 447K | -533K | -11.3M | 1.73M | ||||
EBT | -864K | 665K | -291K | -9M | 4.83M | ||||
Operating Income | 702K | 957K | 4.25M | 1.12M | -593K |
- Stock Market
- Stocks
- GRIN Stock
- Financials Grown Rogue International Inc.
- Business Segments
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
